COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Monday 28 June 2021
CureVac back into BOTTOM TEN after tough week
Adaptive is the top performer in the BOTTOM TEN, moving up 16% in its overall return.
CureVac tumbles into BOTTOM TEN with poor clinical results.
No comments:
Post a Comment